Formerly known as Beijing Increase Biological Institute. It was established in 1999 and established the Clinical Affairs Department in 2007 to start interventional clinical trial research. Located on the 7th floor of Building 10, Pomegranate Center, 88 Liuxiang Road, Fengtai District, Beijing, with an office area of nearly 300 m2.
The company currently employs nearly 20 people and has four business and support departments underits jurisdiction: Project Operation Department, Medical Department, Support Management Department and Finance Department. In addition, the company has 6 exclusive expert technical committees. The expert advisory groups are all academic leaders in various disciplines or experts in the fields of clinical medicine, drug review, pharmacodynamics, toxicology, and biostatistics, with academic authority and rich resources. It provides strong quality assurance for the implementation of clinical trials, and provides strategic or technical support for the sponsor's follow-up new drug review and application for national policy support.
We are committed to providing comprehensive and professional research consulting services for outstanding domestic and foreign companies. Its main business covers drug registration, drug clinical trials, medical device clinical trials, medical technical support, academic promotion and project evaluation:
a) Drug clinical research services: new drug (TCM, chemical drug, biological product) research from phase I to IV clinical trials; Post-marketing re-evaluation of clinical research (including large-scale evidence-based medicine research and post-marketing academic promotion, etc.); clinical research of TCM injections; registration and clinical research of import drug; international multi-center clinical trials; third-party audits of clinical projects; clinical trials of protected TCM; pharmacoeconomics research; the consistency evaluation of the quality and efficacy of generic drugs and bio equivalent research; clinical research on formula food for special medical purposes; clinical research on health products, etc.
b) Medical device clinical research services: registration regulations; clinical trials.
c) Registration and application consultation services: consultation on national registration & application policies and the application & registration services of drugs, equipment and health products.
d) Medical support and academic promotion services: program design and consultation; academic conferences and demonstrations; project feasibility evaluation.
Scan the WeChat QR code